Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: J Hepatol. 2015 Jun 10;63(4):962–970. doi: 10.1016/j.jhep.2015.05.031

Figure 4. Accumulation of Osteopontin(+) and YAP(+)RDC in human NASH.

Figure 4

A. Osteopontin (OPN) immunohistochemistry (brown) in liver sections from the same patients. B. Correlation between aSMA and osteopontin immunostaining. C. Left panel, double immunohistochemistry for YAP and OPN. Right panel, correlation between YAP and OPN immunostaining. Mean±SEM are graphed.

HHS Vulnerability Disclosure